Study Designs

It includes randomized, two-period, two-sequence, single dose cross-over design, parallel design and replicate designs. Absolute and Relative bioavailability are discussed. Pharmacokinetics and Pharmacodynamics of the study designs make an important role.

  • Bioequivalence Study Design
  • Bioavailability Study design
  • Randomized, two-period, two-sequence, single dose cross-over design, parallel design and replicate designs
  • Absolute bioavailability
  • Relative bioavailability
  • Pharmacokinetics & pharmacodynamics

Related Conference of Study Designs

July 03-05, 2017

4th Annual Congress on Drug Discovery & Designing

Bangkok, Thailand
August 10-12, 2017

8th Asian Biologics and Biosimilars Congress

Beijing, China
Sep 20-21, 2017

10th Pharmacovigilance Congress

Charlotte, North Carolina, USA
September 25-26, 2017(10 Plenary Forums- 1 Event)

7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR

Chicago, Illinois, USA
September 25-26, 2017
(10 Plenary Forums - 1Event)

6th International Summit on GMP, GCP & Quality Control

Chicago, Illinois, USA
October 02-04, 2017

World Congress on Antibiotics: R&D, Market

Atlanta, USA
October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 16-17, 2017

4th European Biopharma Congress

Vienna, Austria
Dec 14-16, 2017

7th Global Mass Spectrometry Congress

Dubai, UAE

Study Designs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in